chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: wanted to report a possible adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (wanted to report a possible adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (wanted to report a possible adverse reaction). At the time of the report, ADVERSE REACTION (wanted to report a possible adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: "little pain" at the injection site; left arm pain returned and lasted for several days; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol. Concomitant products included ROSUVASTATIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days). At the time of the report, INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Flushing, Influenza like illness, Limb discomfort, Myalgia
Clinical narrative: "left arm is not as sore today"; left "arm felt like it was going to fall off"; "was in tears"; face became flushed; "flu-type symptoms"; couldn't hardly move her left arm; "achy feeling"; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms") and VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included PRAVASTATIN for High cholesterol.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) and PAIN ("achy feeling"). On 05-Feb-2021, the patient experienced MYALGIA ("left arm is not as sore today"). At the time of the report, LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm), PAIN ("achy feeling") and MYALGIA ("left arm is not as sore today") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included two baby aspirin tablets for the adverse events.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site movement impairment
Clinical narrative: "left arm is not as sore today"; left "arm felt like it was going to fall off"; "was in tears"; face became flushed; "flu-type symptoms"; couldn't hardly move her left arm; "achy feeling"; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms") and VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included PRAVASTATIN for High cholesterol.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) and PAIN ("achy feeling"). On 05-Feb-2021, the patient experienced MYALGIA ("left arm is not as sore today"). At the time of the report, LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm), PAIN ("achy feeling") and MYALGIA ("left arm is not as sore today") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included two baby aspirin tablets for the adverse events.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: Round circle at injection site; Itching at injection site; Red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Round circle at injection site), INJECTION SITE PRURITUS (Itching at injection site) and INJECTION SITE ERYTHEMA (Red at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03L20a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and RALOXIFENE HYDROCHLORIDE (EVISTA) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MASS (Round circle at injection site), INJECTION SITE PRURITUS (Itching at injection site) and INJECTION SITE ERYTHEMA (Red at injection site). At the time of the report, INJECTION SITE MASS (Round circle at injection site), INJECTION SITE PRURITUS (Itching at injection site) and INJECTION SITE ERYTHEMA (Red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included unspecified medication for blood pressure. No treatment details were reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received on 27 Apr 2021(TCR) included: No new information
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: a little itchy; body rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (a little itchy) and RASH (body rash) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (a little itchy) and RASH (body rash). At the time of the report, PRURITUS (a little itchy) and RASH (body rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.   This case was linked to MOD21-034959, MOD21-029945 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21-jun-2021 , contain No new information
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: warmness around the injection site; Red circle around injection site; Red circle around injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warmness around the injection site), VACCINATION SITE RASH (Red circle around injection site) and VACCINATION SITE ERYTHEMA (Red circle around injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  The patient's past medical history included Congestive heart failure. Concomitant products included METFORMIN and APIXABAN (ELIQUIS) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warmness around the injection site), VACCINATION SITE RASH (Red circle around injection site) and VACCINATION SITE ERYTHEMA (Red circle around injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warmness around the injection site), VACCINATION SITE RASH (Red circle around injection site) and VACCINATION SITE ERYTHEMA (Red circle around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications for Congested Heart Failure; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling on the face, leg and foot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on the face, leg and foot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling on the face, leg and foot). At the time of the report, PARAESTHESIA (Tingling on the face, leg and foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.   This case was linked to MOD-2021-020765 (Patient Link).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: COVID arm after first shot; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE REACTION (COVID arm after first shot) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (COVID arm after first shot). At the time of the report, ADVERSE REACTION (COVID arm after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment details were reported.     This case was linked to MOD-2021-021631 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.      Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: No specific follow-up information recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Erythema, Fatigue
Clinical narrative: whole face from the nose down was red; lost her voice; extremely exhausted; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely exhausted), ERYTHEMA (whole face from the nose down was red) and APHONIA (lost her voice) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL ARTHRITIS PAIN) for Arthritis, LEVOTHYROXINE, FAMOTIDINE, Estrogen ring and METRONIDAZOLE (VANDAZOLE) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced FATIGUE (extremely exhausted). On 04-Feb-2021, the patient experienced ERYTHEMA (whole face from the nose down was red) and APHONIA (lost her voice). On 05-Feb-2021, APHONIA (lost her voice) had resolved. At the time of the report, FATIGUE (extremely exhausted) outcome was unknown and ERYTHEMA (whole face from the nose down was red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: red spot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red spot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (red spot). At the time of the report, RASH MACULAR (red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: [Arm] hurt; Nauseous off and on; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY ([Arm] hurt) and NAUSEA (Nauseous off and on) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY ([Arm] hurt) and NAUSEA (Nauseous off and on). At the time of the report, PAIN IN EXTREMITY ([Arm] hurt) and NAUSEA (Nauseous off and on) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication reported Case is cross linked to MOD21-036255
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood test, Maternal exposure during pregnancy, Pregnancy test, Ultrasound antenatal screen
Clinical narrative: received vaccine at 31 weeks pregnant; arm was mildly sore at the site of the injection; This spontaneous prospective pregnancy case was reported by an occupational therapist and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) and VACCINATION SITE PAIN (arm was mildly sore at the site of the injection) in a 39-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-Mar-2021. On 25-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) and VACCINATION SITE PAIN (arm was mildly sore at the site of the injection). On 25-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) had resolved. At the time of the report, VACCINATION SITE PAIN (arm was mildly sore at the site of the injection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2020, Pregnancy test: positive (Positive) positive. On an unknown date, Blood glucose: good (normal) good. On an unknown date, Blood test: good (normal) blood test to look for abnormalities- good. On an unknown date, Ultrasound antenatal screen: good (normal) good.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: received vaccine at 31 weeks pregnant; arm was mildly sore at the site of the injection; This spontaneous prospective pregnancy case was reported by an occupational therapist and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) and VACCINATION SITE PAIN (arm was mildly sore at the site of the injection) in a 39-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-Mar-2021. On 25-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) and VACCINATION SITE PAIN (arm was mildly sore at the site of the injection). On 25-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (received vaccine at 31 weeks pregnant) had resolved. At the time of the report, VACCINATION SITE PAIN (arm was mildly sore at the site of the injection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2020, Pregnancy test: positive (Positive) positive. On an unknown date, Blood glucose: good (normal) good. On an unknown date, Blood test: good (normal) blood test to look for abnormalities- good. On an unknown date, Ultrasound antenatal screen: good (normal) good.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Dizziness, Dyspnoea, Presyncope
Clinical narrative: feel like going to pass out; difficulty breathing; dizziness; weakness; losing his balance; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (feel like going to pass out), DYSPNOEA (difficulty breathing), DIZZINESS (dizziness), ASTHENIA (weakness) and BALANCE DISORDER (losing his balance) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PRESYNCOPE (feel like going to pass out), DYSPNOEA (difficulty breathing), DIZZINESS (dizziness), ASTHENIA (weakness) and BALANCE DISORDER (losing his balance). At the time of the report, PRESYNCOPE (feel like going to pass out), DYSPNOEA (difficulty breathing), DIZZINESS (dizziness), ASTHENIA (weakness) and BALANCE DISORDER (losing his balance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included Aspirin
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Pain; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M30A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Injection site discomfort, Injection site pain
Clinical narrative: Discomfort at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOMFORT (Discomfort at injection site) and INJECTION SITE PAIN (Pain at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOMFORT (Discomfort at injection site) and INJECTION SITE PAIN (Pain at injection site). At the time of the report, INJECTION SITE DISCOMFORT (Discomfort at injection site) and INJECTION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Injection site pruritus, Pyrexia
Clinical narrative: Headache; Chills; Fever; Red rash; Burning rash; itchy rash at the injection site; Tender at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site), INJECTION SITE PAIN (Tender at the injection site) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site) and INJECTION SITE PAIN (Tender at the injection site). On 19-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site), INJECTION SITE PAIN (Tender at the injection site), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Tylenol
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: Headache; Chills; Fever; Red rash; Burning rash; itchy rash at the injection site; Tender at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site), INJECTION SITE PAIN (Tender at the injection site) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site) and INJECTION SITE PAIN (Tender at the injection site). On 19-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH (Burning rash), INJECTION SITE PRURITUS (itchy rash at the injection site), INJECTION SITE PAIN (Tender at the injection site), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Tylenol
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore Arm). At the time of the report, VACCINATION SITE PAIN (Sore Arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not reported.   Treatment information was not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dysgeusia, Pyrexia, Thirst
Clinical narrative: Metallic taste in her mouth; Constantly thirsty; Spike of fever 99.4; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth), THIRST (Constantly thirsty) and PYREXIA (Spike of fever 99.4) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth), THIRST (Constantly thirsty) and PYREXIA (Spike of fever 99.4). At the time of the report, DYSGEUSIA (Metallic taste in her mouth), THIRST (Constantly thirsty) and PYREXIA (Spike of fever 99.4) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 99.4 (High) 99.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Outcome of the events updated to recovering (patient stated that she was fine).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Laziness
Clinical narrative: feels lazy; fatigue and gets easily tired; This spontaneous case was reported by a consumer and describes the occurrence of LAZINESS (feels lazy) and FATIGUE (fatigue and gets easily tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced LAZINESS (feels lazy) and FATIGUE (fatigue and gets easily tired).   At the time of the report, LAZINESS (feels lazy) and FATIGUE (fatigue and gets easily tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Inflammation
Clinical narrative: Knot on forearm which is on the same arm of injection; Slight chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Knot on forearm which is on the same arm of injection) and CHILLS (Slight chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (Knot on forearm which is on the same arm of injection) and CHILLS (Slight chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Knot on forearm which is on the same arm of injection) and CHILLS (Slight chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 22-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19).   At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, COVID-19: negative (Negative) On 18-FEB-2021, patient tested negative for COVID-19.. On 22-Feb-2021, COVID-19: positive (Positive) On 22-FEB-2021, patient tested positive for COVID-19..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   It is reported that on 23-FEB-2021, patient is scheduled to have antibody infusions.  Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Itching at the injection arm; Redness at the injection arm; Swelling at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itching at the injection arm), INJECTION SITE ERYTHEMA (Redness at the injection arm) and INJECTION SITE SWELLING (Swelling at the injection arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Itching at the injection arm), INJECTION SITE ERYTHEMA (Redness at the injection arm) and INJECTION SITE SWELLING (Swelling at the injection arm). At the time of the report, INJECTION SITE PRURITUS (Itching at the injection arm), INJECTION SITE ERYTHEMA (Redness at the injection arm) and INJECTION SITE SWELLING (Swelling at the injection arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products used were not provided by the reporter.   Treatment medications was  not specified.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder and Hypertension.   On 18-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.            Concomitant medications included heart med, high blood pressure. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up information received on 13 Jul 2021 contains no new information
Sex: M
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: vaccine was frozen then put it in refrigerator about 24 hours/vial is refreeze; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine was frozen then put it in refrigerator about 24 hours/vial is refreeze) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine was frozen then put it in refrigerator about 24 hours/vial is refreeze). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine was frozen then put it in refrigerator about 24 hours/vial is refreeze) had resolved. Not Provided    For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea
Clinical narrative: About 3-4 days later I am having Shortness of Breath. Its not severe , I walk about a mile everyday; I experienced chills for 4-5 hours next day afternoon; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (About 3-4 days later I am having Shortness of Breath. Its not severe , I walk about a mile everyday) and CHILLS (I experienced chills for 4-5 hours next day afternoon) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 03-Dec-2020. Concomitant products included WARFARIN, ATORVASTATIN CALCIUM (LIPITOR), LISINOPRIL and LEVOTHYROXINE for an unknown indication.  On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 13-Feb-2021, the patient experienced CHILLS (I experienced chills for 4-5 hours next day afternoon).   On 15-Feb-2021, the patient experienced DYSPNOEA (About 3-4 days later I am having Shortness of Breath. Its not severe , I walk about a mile everyday). At the time of the report, DYSPNOEA (About 3-4 days later I am having Shortness of Breath. Its not severe , I walk about a mile everyday) and CHILLS (I experienced chills for 4-5 hours next day afternoon) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort
Clinical narrative: Tenderness in neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Tenderness in neck) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Tenderness in neck). At the time of the report, MUSCULOSKELETAL DISCOMFORT (Tenderness in neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MODERNATX, INC.-MOD-2021-086393 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Reporter's information was added. On 29-Apr-2021: Email, NNI on husband event.; Sender's Comments:  MODERNATX, INC.-MOD-2021-086393:Crosslink
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Vomiting
Clinical narrative: aches; Fever; chills; Vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache). At the time of the report, PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache) had not resolved.            No concomitant product use was reported   No treatment information was provided   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Nausea
Clinical narrative: fever; joint pain; nausea; headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported.   This case was linked to MOD-2021-039059 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up was received on 21 Apr 2021 included no new information; Sender's Comments:  MOD-2021-039059:Crosslinked to first dose
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; joint pain; nausea; headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), ARTHRALGIA (joint pain), NAUSEA (nausea), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported.   This case was linked to MOD-2021-039059 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up was received on 21 Apr 2021 included no new information; Sender's Comments:  MOD-2021-039059:Crosslinked to first dose
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Mass, Pruritus, Rash, Sleep disorder
Clinical narrative: breaking out in hives on  both arms, chest, then eventually on  face; didn't sleep well; itch goes away but the rash does not go away; Bumps under skin; itch; Tired, fatigue for several days; Tightness/ throat contractions in throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Tightness/ throat contractions in throat), MASS (Bumps under skin), URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), SLEEP DISORDER (didn't sleep well) and PRURITUS (itch) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 Year.   On 12-Feb-2021, the patient experienced THROAT TIGHTNESS (Tightness/ throat contractions in throat) and FATIGUE (Tired, fatigue for several days).   On 16-Feb-2021, the patient experienced MASS (Bumps under skin) and PRURITUS (itch).   On 19-Feb-2021, the patient experienced URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), SLEEP DISORDER (didn't sleep well) and RASH (itch goes away but the rash does not go away). The patient was treated with CHLORPHENIRAMINE MALEATE for Allergy, at a dose of 4 milligram.   At the time of the report, THROAT TIGHTNESS (Tightness/ throat contractions in throat) and PRURITUS (itch) had resolved, MASS (Bumps under skin), URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), FATIGUE (Tired, fatigue for several days) and RASH (itch goes away but the rash does not go away) had not resolved and SLEEP DISORDER (didn't sleep well) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Urticaria
Clinical narrative: breaking out in hives on  both arms, chest, then eventually on  face; didn't sleep well; itch goes away but the rash does not go away; Bumps under skin; itch; Tired, fatigue for several days; Tightness/ throat contractions in throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Tightness/ throat contractions in throat), MASS (Bumps under skin), URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), SLEEP DISORDER (didn't sleep well) and PRURITUS (itch) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 Year.   On 12-Feb-2021, the patient experienced THROAT TIGHTNESS (Tightness/ throat contractions in throat) and FATIGUE (Tired, fatigue for several days).   On 16-Feb-2021, the patient experienced MASS (Bumps under skin) and PRURITUS (itch).   On 19-Feb-2021, the patient experienced URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), SLEEP DISORDER (didn't sleep well) and RASH (itch goes away but the rash does not go away). The patient was treated with CHLORPHENIRAMINE MALEATE for Allergy, at a dose of 4 milligram.   At the time of the report, THROAT TIGHTNESS (Tightness/ throat contractions in throat) and PRURITUS (itch) had resolved, MASS (Bumps under skin), URTICARIA (breaking out in hives on  both arms, chest, then eventually on  face), FATIGUE (Tired, fatigue for several days) and RASH (itch goes away but the rash does not go away) had not resolved and SLEEP DISORDER (didn't sleep well) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.